FDA Roundup: December 5, 2023 (mar, 05 dic 2023)
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
>> Leer más

Ongoing | Cancer Accelerated Approvals (Tue, 05 Dec 2023)
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit.
>> Leer más